Cargando…

Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins

Viral entry is the first stage in the virus replication cycle and, for enveloped viruses, is mediated by virally encoded glycoproteins. Viral glycoproteins have different receptor affinities and triggering mechanisms. We employed vesicular stomatitis virus (VSV), a BSL-2 enveloped virus that can inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lay Mendoza, Maria Fernanda, Acciani, Marissa Danielle, Levit, Courtney Nina, Santa Maria, Christopher, Brindley, Melinda Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766484/ https://www.ncbi.nlm.nih.gov/pubmed/33348746 http://dx.doi.org/10.3390/v12121457

Ejemplares similares

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
por: Bishnoi, Suman, et al.
Publicado: (2018)

In Vitro and In Vivo Attenuation of Vesicular Stomatitis Virus (VSV) by Phosphoprotein Deletion
por: Wongthida, Phonphimon, et al.
Publicado: (2016)

SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus
por: Havranek, Katherine Elizabeth, et al.
Publicado: (2020)

Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypes
por: Logan, Nicola, et al.
Publicado: (2016)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019)

Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
por: Poetsch, Joseph H, et al.
Publicado: (2019)

Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies
por: Logan, Nicola, et al.
Publicado: (2016)

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
por: Pinski, Amanda N., et al.
Publicado: (2020)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs
por: Cao, Wenguang, et al.
Publicado: (2023)

Cholesterol supplementation during production increases the infectivity of retroviral and lentiviral vectors pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G)
por: Chen, Yong, et al.
Publicado: (2009)

Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
por: Havranek, Katherine E., et al.
Publicado: (2021)

Usp18 Expression in CD169(+) Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV
por: Friedrich, Sarah-Kim, et al.
Publicado: (2020)

Scrambled or flipped: 5 facts about how cellular phosphatidylserine localization can mediate viral replication
por: Acciani, Marissa Danielle, et al.
Publicado: (2022)

Identification of Residues in Lassa Virus Glycoprotein Subunit 2 That Are Critical for Protein Function
por: Willard, Katherine A., et al.
Publicado: (2018)

Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots
por: Gillespie, Paul F., et al.
Publicado: (2023)

Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein
Publicado: (1979)

First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine
por: Fuchs, JD, et al.
Publicado: (2012)

Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector (VSV(MT)) in golden syrian hamster
por: Ke, Yong, et al.
Publicado: (2023)

Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model
por: Lee, Ha-Na, et al.
Publicado: (2021)

Studies on the mechanism for entry of vesicular stomatitis virus glycoprotein g mRNA into membrane-bound polyribosome complexes
por: Grubman, MJ, et al.
Publicado: (1977)

Emerging Biomedical Applications of the Vesicular Stomatitis Virus Glycoprotein
por: Rehman, Sheeba, et al.
Publicado: (2022)

Aphthæ, or Vesicular Stomatitis of the Horse
por: Hutcheon, D.
Publicado: (1898)

Chikungunya virus entry and infectivity is primarily facilitated through cell line dependent attachment factors in mammalian and mosquito cells
por: Reyes Ballista, Judith Mary, et al.
Publicado: (2023)

Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent
por: Alajez, Nehad M, et al.
Publicado: (2012)

Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins
por: Fukushi, Shuetsu, et al.
Publicado: (2007)

The synthetic futures of vesicular stomatitis virus
por: Overend, Christopher, et al.
Publicado: (2012)

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
por: Xiong, Hua-Long, et al.
Publicado: (2020)

Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights
por: Elebeedy, Dalia, et al.
Publicado: (2023)

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector
por: Liang, Ziteng, et al.
Publicado: (2023)

Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface
por: Kreis, Thomas E., et al.
Publicado: (1986)

The phosphoinositide 3-kinase inhibitor ZSTK474 increases the susceptibility of osteosarcoma cells to oncolytic vesicular stomatitis virus VSVΔ51 via aggravating endoplasmic reticulum stress
por: Jiang, Jinqiong, et al.
Publicado: (2021)

Establishment of Replication Deficient Vesicular Stomatitis Virus for Studies of PEDV Spike-Mediated Cell Entry and Its Inhibition
por: Luo, Huaye, et al.
Publicado: (2023)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
por: Cham, Lamin B., et al.
Publicado: (2019)

EFFECT OF FORMALIN ON THE VIRUS OF VESICULAR STOMATITIS OF HORSES
por: Olitsky, Peter K., et al.
Publicado: (1928)

Vesicular stomatitis forecasting based on Google Trends
por: Wang, JianYing, et al.
Publicado: (2018)

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment
por: Monath, Thomas P., et al.
Publicado: (2019)

Ebola virus (EBOV) infection: Therapeutic strategies
por: De Clercq, Erik
Publicado: (2015)

Reconstituted G protein-lipid vesicles from vesicular stomatitus virus and their inhition of VSV infection
por: Miller, DK
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_8bea24oggbgqlkg62qu6vavph8